Big data, medicines safety and pharmacovigilance

被引：5

作者：

Hussain, Rabia ^{[1
]}

机构：

[1] Univ Lahore, Fac Pharm, Lahore 54000, Pakistan

来源：

JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE | 2021年 / 14卷 / 01期

关键词：

Big data; Medicines safety; Pharmacovigilance; Artificial intelligence; Social media; COVID-19;

D O I：

10.1186/s40545-021-00329-4

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

页数：3

共 16 条

[1] The hope, hype and reality of Big Data for pharmacovigilance [J].

Bate, Andrew ;

Reynolds, Robert F. ;

Caubel, Patrick .

THERAPEUTIC ADVANCES IN DRUG SAFETY, 2018, 9 (01) :5-11

[2]

Beninger P, 2021, CLIN THER, V43, P369, DOI 10.1016/j.clinthera.2020.12.019

[3] Pharmacovigilance in the era of social media: Discovering adverse drug events cross-relating Twitter and PubMed [J].

De Rosa, Michela ;

Fenza, Giuseppe ;

Gallo, Alessandro ;

Gallo, Mariacristina ;

Loia, Vincenzo .

FUTURE GENERATION COMPUTER SYSTEMS-THE INTERNATIONAL JOURNAL OF ESCIENCE, 2021, 114 :394-402

[4] Novel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis [J].

Harpaz, R. ;

DuMouchel, W. ;

Shah, N. H. ;

Madigan, D. ;

Ryan, P. ;

Friedman, C. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (06) :1010-1021

[5] Artificial Intelligence in Pharmacovigilance: Scoping Points to Consider [J].

Hauben, Manfred ;

Hartford, Craig G. .

CLINICAL THERAPEUTICS, 2021, 43 (02) :372-379

[6]

Hussain R., 2020, Global Pharmaceutical Policy, P1, DOI DOI 10.1007/978-981-15-2724-1_1

[7] Current status and future prospects of pharmacovigilance in Pakistan [J].

Hussain, Rabia ;

Hassali, Mohamed Azmi .

JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2019, 12 (01)

[8] Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU [J].

Joppi, Roberta ;

Bertele', Vittorio ;

Garattini, Silvio .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (04) :1009-1024

[9]

Keane PA, 2021, LANCET, V397, P1254, DOI 10.1016/S0140-6736(21)00722-4

[10]

Li J., UNEXPECTED OPPORTUNI

← 1 2 →